New Zealand markets open in 9 hours 38 minutes

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
38.90-0.40 (-1.02%)
At close: 04:00PM EDT
39.07 +0.17 (+0.44%)
After hours: 07:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 55.69B
Enterprise value 64.74B
Trailing P/E 67.07
Forward P/E 19.53
PEG ratio (5-yr expected) 2.01
Price/sales (ttm)4.53
Price/book (mrq)3.23
Enterprise value/revenue 5.25
Enterprise value/EBITDA 23.64

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-12.51%
S&P500 52-week change 3-16.88%
52-week high 347.50
52-week low 334.98
50-day moving average 340.73
200-day moving average 341.46

Share statistics

Avg vol (3-month) 36.67M
Avg vol (10-day) 36.81M
Shares outstanding 51.43B
Implied shares outstanding 6N/A
Float 81.43B
% held by insiders 10.24%
% held by institutions 194.36%
Shares short (30 Aug 2022) 415.21M
Short ratio (30 Aug 2022) 42.7
Short % of float (30 Aug 2022) 41.07%
Short % of shares outstanding (30 Aug 2022) 41.06%
Shares short (prior month 28 Jul 2022) 413.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 305 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 7.17%
Operating margin (ttm)17.20%

Management effectiveness

Return on assets (ttm)4.19%
Return on equity (ttm)5.33%

Income statement

Revenue (ttm)12.33B
Revenue per share (ttm)8.64
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)8.24B
Net income avi to common (ttm)829M
Diluted EPS (ttm)0.57
Quarterly earnings growth (yoy)39.80%

Balance sheet

Total cash (mrq)276M
Total cash per share (mrq)0.19
Total debt (mrq)9.33B
Total debt/equity (mrq)54.08
Current ratio (mrq)1.31
Book value per share (mrq)12.06

Cash flow statement

Operating cash flow (ttm)1.19B
Levered free cash flow (ttm)984.12M